Fulgent Genetics, Inc.
FLGT
$20.31
-$0.21-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -95.82% | 59.80% | -68.17% | 35.30% | 89.50% |
| Total Depreciation and Amortization | -4.41% | 4.59% | -3.79% | -7.65% | 1.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.68% | -55.06% | 101.28% | 2.93% | -92.75% |
| Change in Net Operating Assets | -160.48% | 162.86% | -896.98% | -152.63% | -52.03% |
| Cash from Operations | -117.71% | 261.31% | -461.94% | -41.03% | -51.34% |
| Capital Expenditure | -24.88% | 80.66% | -50.93% | -219.13% | -30.59% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 123.53% | -93.41% | -22.99% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 237.03% | -183.12% | 40.79% | 146.63% | -258.12% |
| Cash from Investing | 201.00% | -405.56% | 23.01% | 115.48% | -294.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -345.59% | 0.00% | 77.41% | 33.11% | 54.43% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -4,266.12% | 43.85% | 20.77% | 71.47% | 92.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,316.51% | 42.33% | 50.52% | 59.17% | 89.18% |
| Foreign Exchange rate Adjustments | 108.21% | -185.35% | 1,844.44% | 86.96% | -147.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 518.81% | 58.21% | -166.46% | 124.38% | -419.44% |